HomeTOP STORIESDaiichi Sankyo sees ENHERTU sales reaching ¥539.9B in FY2024 amid oncology momentum Daiichi Sankyo sees ENHERTU sales reaching ¥539.9B in FY2024 amid oncology momentum By rogerjudd February 1, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleJanus Henderson projects ETF growth and targets private credit expansion in 2025Next articleCDC Web Pages and Data Vanish Following Trump’s DEI and Gender Orders latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
